Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fischer Medical VenturesBOM:524743 -3.25%41 Return-on-Tangible-Asset is 2.28% as of Jun. 2026, which is 175% above its 10-year median of 0.83. GuruFocus rates BOM:524743 with a GF Score™ of 41/100 and a GF Value™ of ₹261.46 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Fischer Medical Ventures ranks better than 66.9% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Fischer Medical Ventures's annualizedNet Income for the quarter that ended in Jun. 2026 was ₹152 Mil. Fischer Medical Ventures's average total tangible assets for the quarter that ended in Jun. 2026 was ₹6,657 Mil. Therefore, Fischer Medical Ventures's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was 2.28%.
The historical rank and industry rank for Fischer Medical Ventures's Return-on-Tangible-Asset or its related term are showing as below:
BOM:524743'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -226.32 Med: 0.83 Max: 71.83
Current: 5.66
During the past 13 years, Fischer Medical Ventures's highest Return-on-Tangible-Asset was 71.83%. The lowest was -226.32%. And the median was 0.83%.
BOM:524743's Return-on-Tangible-Asset is ranked better than 66.9% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 0.925
vs BOM:524743: 5.66
Fischer Medical Ventures (BOM:524743) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Fischer Medical Ventures Return-on-Tangible-Asset Related Terms
Fischer Medical Ventures Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Fischer Medical Ventures's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fischer Medical Ventures Return-on-Tangible-Asset Chart
BOM:524743 vs ABT, SYK, MDT: Return-on-Tangible-Asset Comparison
For the Medical Devices subindustry, Fischer Medical Ventures's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fischer Medical Ventures Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fischer Medical Ventures's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Fischer Medical Ventures's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 2.28% mean?
Fischer Medical Ventures (BOM:524743) has a Return-on-Tangible-Asset of 2.28% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Fischer Medical Ventures and its competitors. This is 175% above median its historical median of 0.83. According to the industry distribution chart, Fischer Medical Ventures ranks #282 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 33.1%.
Is Fischer Medical Ventures' Return-on-Tangible-Asset too high?
Fischer Medical Ventures' current Return-on-Tangible-Asset of 2.28% is 175% above median its 10-year median of 0.83. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.93. Fischer Medical Ventures' value of 2.28% is 146.5% above this industry median. Based on the distribution chart, Fischer Medical Ventures ranks #282 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Fischer Medical Ventures has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Fischer Medical Ventures' Return-on-Tangible-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Fischer Medical Ventures ranks #282 out of 852 companies for Return-on-Tangible-Asset. This puts Fischer Medical Ventures in the upper half of its industry. The industry median Return-on-Tangible-Asset is 0.93. Fischer Medical Ventures' value of 2.28% is 146.5% above this benchmark. While the company's 10-year median is 0.83 vs. the industry median of 0.93, Fischer Medical Ventures has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.93, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fischer Medical Ventures's current Return-on-Tangible-Asset of 2.28% is 146.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Fischer Medical Ventures and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fischer Medical Ventures's current Return-on-Tangible-Asset is 2.28%, which is 175% above median its own 10-year median of 0.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fischer Medical Ventures stock overvalued right now?
Based on GuruFocus' analysis, Fischer Medical Ventures (BOM:524743) is currently considered Possible Value Trap. The stock's GF Value™ is ₹261.46, compared to a current price of ₹36.03 — trading 86.2% below its estimated fair value. The current Return-on-Tangible-Asset is 2.28%, which is 175% above median its 10-year median of 0.83 and 146.5% above the Medical Devices & Instruments industry median of 0.93. Fischer Medical Ventures' overall GF Score™ is 41/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Fischer Medical Ventures (BOM:524743), the current Return-on-Tangible-Asset is 2.28% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fischer Medical Ventures (BOM:524743) Overvalued in 2026?
Based on GuruFocus' analysis, Fischer Medical Ventures stock appears to be undervalued.
The current stock price of ₹36.03 is trading 86.2% below its estimated GF Value™ of ₹261.46.
GuruFocus considers Fischer Medical Ventures to be Possible Value Trap.
Key valuation signals for BOM:524743:
Return-on-Tangible-Asset: 2.28% (175% above median its 10-year median of 0.83)
GF Value™: ₹261.46 vs. price of ₹36.03 (86.2% below fair value)
Industry Position: 146.5% above the Medical Devices & Instruments median (#282 of 852)
No single metric tells the full story. See the BOM:524743 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fischer Medical Ventures Ltd is engaged in developing and trading of Medical Equipment including cutting-edge Magnetic Resonance Imaging (MRI) systems in India.
41GF Score
Get the complete analysis for BOM:524743
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524743 has been successfully added to your 
